Nylim GBL Ety R&D LDR ETF-UiWRNDETF

13F holders, Q1 2024 (March 31)
4holders
$28.68avg. 13F price*

At the end of Q1 2024, 4 institutions reported holding Nylim GBL Ety R&D LDR ETF-Ui (WRND) in their 13F filings. The largest holders were New York Life Investment Management LLC ($5.4M), GTS Securities LLC ($512K) and UBS Group AG ($2K).

Company
Nylim GBL Ety R&D LDR ETF-Ui
Filed as
INDEXIQ ETF TR (Q1 2024)
CUSIP
45409B255
Latest filing quarter
Q2 2026

History

Number of 13F holders

012345 Q1 2024: 4Q1 2024Q2 2024: 4Q2 2024Q3 2024: 4Q3 2024Q4 2024: 4Q4 2024Q1 2025: 3Q1 2025Q2 2025: 3Q2 2025Q3 2025: 3Q3 2025Q4 2025: 1Q4 2025Q1 2026: 4Q1 2026Q2 2026: 5Q2 2026

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions0$0
Exits3$1.8M

Ownership 4 holders

New York Life Investment Management LLC 0.05% No change 190,000 $5.4M
GTS Securities LLC 0.01% Add +13.2% 17,840 $512K
UBS Group AG 0.00% Reduce -75.0% 70 $2K
Tower Research Capital LLC (TRC) 0.00% No change 11 $315

"% of holder's portfolio" is WRND's weight in each manager's 13F, not the share of Nylim GBL Ety R&D LDR ETF-Ui the manager owns.